Serial Number | 98502685 |
Word Mark | BEKOOOL |
Filing Date | Tuesday, April 16, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Tuesday, November 5, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Anti-itch preparations; anti-itch transdermal patches |
Goods and Services | Eye masks for therapeutic purposes; therapeutic eye masks to provide migraine relief |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, April 16, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, April 16, 2024 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Kobayashi Pharmaceutical Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Osaka-shi, Osaka 541-0045 JP |
Event Date | Event Description |
Tuesday, April 16, 2024 | NEW APPLICATION ENTERED |
Sunday, September 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 29, 2024 | ASSIGNED TO EXAMINER |
Tuesday, November 5, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, November 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, November 5, 2024 | NON-FINAL ACTION WRITTEN |